Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-526,376
Closed -$9.97M 93
2023
Q2
$9.97M Sell
526,376
-1,316,600
-71% -$23.1M 0.35% 74
2023
Q1
$28.1M Buy
+1,842,976
New +$24M 0.93% 39

Other funds holding ETNB

Avidity Partners Management's ETNB Position: Q3 2023 in Review

Avidity Partners Management sold out of 89bio (ETNB) in Q3 2023, closing a stake of 526,376 shares — an estimated $9.97M sold.

Avidity Partners Management first reported a position in ETNB in Q1 2023 and held it in 2 quarters. The position peaked at $28.1M in Q1 2023. 160 funds tracked by Wall St. Rank hold ETNB as of Q3 2023.

  • Avidity Partners Management reported no remaining 89bio position as of Q3 2023 after selling out during the quarter.
  • Avidity Partners Management sold 526,376 89bio shares in Q3 2023, an estimated $9.97M.
  • Avidity Partners Management first reported a position in 89bio in Q1 2023 and held it in 2 quarters.
  • Avidity Partners Management's 89bio position peaked at $28.1M in Q1 2023.
  • 160 funds tracked by Wall St. Rank held 89bio as of Q3 2023.

Based on Avidity Partners Management's 13F filing for Q3 2023, filed 14 Nov 2023.